Li Weiyong, Worosila Gregory D
Global Analytical Development, Johnson & Johnson Pharmaceutical Research & Development, LLC 1000 Route 202, Raritan, NJ 08869, USA.
Int J Pharm. 2005 May 13;295(1-2):213-9. doi: 10.1016/j.ijpharm.2005.02.019.
This research note demonstrates the simultaneous quantitation of a pharmaceutical active ingredient and three excipients in a simulated powder blend containing acetaminophen, Prosolv and Crospovidone. An experimental design approach was used in generating a 5-level (%, w/w) calibration sample set that included 125 samples. The samples were prepared by weighing suitable amount of powders into separate 20-mL scintillation vials and were mixed manually. Partial least squares (PLS) regression was used in calibration model development. The models generated accurate results for quantitation of Crospovidone (at 5%, w/w) and magnesium stearate (at 0.5%, w/w). Further testing of the models demonstrated that the 2-level models were as effective as the 5-level ones, which reduced the calibration sample number to 50. The models had a small bias for quantitation of acetaminophen (at 30%, w/w) and Prosolv (at 64.5%, w/w) in the blend. The implication of the bias is discussed.
本研究报告展示了在含有对乙酰氨基酚、Prosolv和交联聚维酮的模拟粉末混合物中同时定量一种药物活性成分和三种辅料的方法。采用实验设计方法生成了一个包含125个样品的五级(%,w/w)校准样品集。通过将适量粉末称入单独的20 mL闪烁瓶中并手动混合来制备样品。在校准模型开发中使用了偏最小二乘(PLS)回归。所生成的模型对交联聚维酮(5%,w/w)和硬脂酸镁(0.5%,w/w)的定量给出了准确结果。对模型的进一步测试表明,二级模型与五级模型一样有效,这将校准样品数量减少到了50个。这些模型在混合物中对乙酰氨基酚(30%,w/w)和Prosolv(64.5%,w/w)的定量存在较小偏差。文中讨论了该偏差的影响。